Edwards Lifesciences Performance

EW -- USA Stock  

USD 153.90  1.72  1.13%

On a scale of 0 to 100 Edwards Lifesciences holds performance score of 23. The firm shows Beta (market volatility) of 0.0 which denotes to the fact that the returns on MARKET and Edwards Lifesciences are completely uncorrelated. Although it is vital to follow to Edwards Lifesciences historical returns, it is good to be conservative about what you can actually do with the information regarding equity current trending patterns. The philosophy towards predicting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By reviewing Edwards Lifesciences technical indicators you can presently evaluate if the expected return of 0.4169% will be sustainable into the future. Please utilizes Edwards Lifesciences Downside Variance as well as the relationship between Accumulation Distribution and Market Facilitation Index to make a quick decision on weather Edwards Lifesciences price patterns will revert.
 Time Horizon     30 Days    Login   to change

Edwards Lifesciences Relative Risk vs. Return Landscape

If you would invest  13,906  in Edwards Lifesciences Corporation on May 23, 2018 and sell it today you would earn a total of  1,312  from holding Edwards Lifesciences Corporation or generate 9.43% return on investment over 30 days. Edwards Lifesciences Corporation is generating 0.4169% of daily returns and assumes 1.1539% volatility on return distribution over the 30 days horizon. Put differently, 10% of equity instruments are less risky than the company on the bases of their historical return distribution and some 93% of equities are expected to be superior in generating returns on investments over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Allowing for the 30-days total investment horizon, Edwards Lifesciences Corporation is expected to generate 1.95 times more return on investment than the market. However, the company is 1.95 times more volatile than its market benchmark. It trades about 0.36 of its potential returns per unit of risk. The DOW is currently generating roughly -0.09 per unit of risk.

Edwards Lifesciences Market Risk Analysis

Sharpe Ratio = 0.3613
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsEW
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Edwards Lifesciences Relative Performance Indicators

Estimated Market Risk
 1.15
  actual daily
 
 90 %
of total potential
  
Expected Return
 0.42
  actual daily
 
 7 %
of total potential
  
Risk-Adjusted Return
 0.36
  actual daily
 
 23 %
of total potential
  
Based on monthly moving average Edwards Lifesciences is performing at about 23% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.

Performance Rating

Edwards Lifesciences Corporation Risk Adjusted Performance Analysis
23 

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corporation are ranked lower than 23 (%) of all global equities and portfolios over the last 30 days.

Edwards Lifesciences Alerts

Equity Alerts and Improvement Suggestions
Edwards Lifesciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its debt commitments
Latest headline from MacroaxisInsider: Sale by Bessler Anita of 3600 shares of Edwards Lifesciences
Additionally see Investing Opportunities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.